4ec581cf B92f 480e 8814 72756efc9f0a 01
Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 70756-704
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 70756-704). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
4ec581cf B92f 480e 8814 72756efc9f0a 02
This is a description of Ranolazine Extended-Release Tablets. Each film-coated tablet contains 500mg of Ranolazine. It is a prescription drug and must be kept out of reach of children. The tablets should be swallowed whole and not crushed, chewed, or broken. The recommended storage temperature is between 20°C-25°C. The medication should be dispensed in a child-resistant container as defined in the USP. The package insert should be consulted for the recommended dosage and administration of the drug. Made in India and manufactured for Lifestar Pharma LLC, this medicine is commonly used in the treatment of chronic angina.*
4ec581cf B92f 480e 8814 72756efc9f0a 03
This is a prescription medication called Ranolazine Extended-Release Tablets. Each tablet contains 1000mg of Ranolazine and comes in a well-closed, child-resistant container. The tablets must be swallowed whole and not crushed, broken, or chewed. The recommended dosage must be checked in the package insert. It should be stored between 20°C -25°C. This medication is manufactured in India for Lifestar Pharma LLC in NJ, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
